Taurine regulation of short term synaptic plasticity in fragile X mice

Journal of Biomedical Science

Volumn 17, Issue SUPPL. 1, 2010, Pages

  El Idrissi, Abdeslem ^a,b   Neuwirth, Lorenz S ^a,b   Lamoreaux, William ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; FRAGILE X MENTAL RETARDATION PROTEIN; MOLECULAR LAYER; TAURINE; FMR1 PROTEIN, MOUSE; PROTEIN SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; CEREBROSPINAL FLUID; CONFERENCE PAPER; DENTATE GYRUS; DEPRESSION; ELECTROSTIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; FRAGILE X SYNDROME; HIPPOCAMPUS; INFORMATION PROCESSING; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; ANIMAL; ARTICLE; BINDING SITE; DISEASE MODEL; DRUG EFFECT; GENETICS; METABOLISM; METHODOLOGY; MOUSE MUTANT; PATHOPHYSIOLOGY; PERFORANT NERVE TRACT; PHYSIOLOGY;

MUS;

ANIMALS; BINDING SITES; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HIPPOCAMPUS; MALE; MICE; MICE, KNOCKOUT; NEURONAL PLASTICITY; PERFORANT PATHWAY; PROTEIN SUBUNITS; TAURINE;

EID: 77956030552     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-S1-S15     Document Type: Conference Paper

References (45)

1. Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. B Bardoni JL Mandel, Curr Opin Genet Dev 2002 12 284 293 10.1016/S0959-437X(02)00300-3 12076671
2. A decade of molecular studies of fragile X syndrome. WT O'Donnell ST Warren, Annu Rev Neurosci 2002 25 315 338 10.1146/annurev.neuro.25.112701.142909 12052912
3. Fmr1 knockout mice: a model to study fragile X mental retardation. CE Bakker C Verheij R Willemsen R Vanderhelm F Oerlemans M Vermey A Bygrave AT Hoogeveen BA Oostra E Reyniers, et al. Cell 1994 78 23 33 8033209
4. Influence of stimulants on electrodermal studies in Fragile X syndrome. RJ Hagerman LJ Miller J McGrath-Clarke K Riley E Goldson SW Harris J Simon K Church J Bonnell TC Ognibene DN McIntosh, Microsc Res Tech 2002 57 168 173 10.1002/jemt.10067 12112453
5. The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. KE Wisniewski SM Segan CM Miezejeski EA Sersen RD Rudelli, Am J Med Genet 1991 38 476 480 10.1002/ajmg.1320380267 2018089
6. Analysis of neocortex in three males with the fragile X syndrome. VJ Hinton WT Brown K Wisniewski RD Rudelli, Am J Med Genet 1991 41 289 294 10.1002/ajmg.1320410306 1724112
7. Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. SA Irwin M Idupulapati ME Gilbert JB Harris AB Chakravarti EJ Rogers RA Crisostomo BP Larsen A Mehta CJ Alcantara, et al. Am J Med Genet 2002 111 140 146 10.1002/ajmg.10500 12210340
8. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. SA Irwin B Patel M Idupulapati JB Harris RA Crisostomo BP Larsen F Kooy PJ Willems P Cras PB Kozlowski, et al. Am J Med Genet 2001 98 161 167 10.1002/1096- 8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B 11223852
9. Neurodevelopmental effects of the FMR-1 full mutation in humans. AL Reiss MT Abrams R Greenlaw L Freund MB Denckla, Nat Med 1995 1 159 167 10.1038/nm0295-159 7585014
10. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. H Siomi MC Siomi RL Nussbaum G Dreyfuss, Cell 1993 74 291 298 10.1016/0092-8674(93)90420-U 7688265
11. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. V Brown P Jin S Ceman JC Darnell WT O'Donnell SA Tenenbaum X Jin Y Feng KD Wilkinson JD Keene, et al. Cell 2001 107 477 487 10.1016/S0092-8674(01)00568-2 11719188
12. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. P Jin DC Zarnescu S Ceman M Nakamoto J Mowrey TA Jongens DL Nelson K Moses ST Warren, Nat Neurosci 2004 7 113 117 10.1038/nn1174 14703574
13. Transgenic mouse model for the fragile X syndrome. RF Kooy R D'Hooge E Reyniers CE Bakker G Nagels K De Boulle K Storm G Clincke PP De Deyn BA Oostra PJ Willems, Am J Med Genet 1996 64 241 245 10.1002/(SICI)1096-8628(19960809)64: 2<241::AID-AJMG1>3.0.CO;2-X 8844056
14. Fragile X mice develop sensory hyperreactivity to auditory stimuli. L Chen M Toth, Neuroscience 2001 103 1043 1050 10.1016/S0306-4522(01)00036-7 11301211
15. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. SA Musumeci P Bosco G Calabrese C Bakker GB De Sarro M Elia R Ferri BA Oostra, Epilepsia 2000 41 19 23 10.1111/j.1528-1157.2000.tb01499.x 10643918
16. Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice. AM Peier DL Nelson, Genomics 2002 80 423 432 10.1006/geno.2002.6849 12376097
17. FMRP involvement in formation of synapses among cultured hippocampal neurons. K Braun M Segal, Cereb Cortex 2000 10 1045 1052 10.1093/cercor/10.10. 1045 11007555
18. Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. R Galvez WT Greenough, Am J Med Genet A 2005 135 155 160 15880753
19. Abnormal development of dendritic spines in FMR1 knock-out mice. EA Nimchinsky AM Oberlander K Svoboda, J Neurosci 2001 21 5139 5146 11438589
20. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Z Li Y Zhang L Ku KD Wilkinson ST Warren Y Feng, Nucleic Acids Res 2001 29 2276 2283 10.1093/nar/29.11.2276 11376146
21. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. KY Miyashiro A Beckel-Mitchener TP Purk KG Becker T Barret L Liu S Carbonetto IJ Weiler WT Greenough J Eberwine, Neuron 2003 37 417 431 10.1016/S0896-6273(03)00034-5 12575950
22. Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. SC Chuang W Zhao R Bauchwitz Q Yan R Bianchi RK Wong, J Neurosci 2005 25 8048 8055 10.1523/JNEUROSCI.1777-05.2005 16135762
23. Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse. A El Idrissi XH Ding J Scalia E Trenkner WT Brown C Dobkin, Neurosci Lett 2005 377 141 146 10.1016/j.neulet.2004.11.087 15755515
24. Altered synaptic plasticity in a mouse model of fragile X mental retardation. KM Huber SM Gallagher ST Warren MF Bear, Proc Natl Acad Sci U S A 2002 99 7746 7750 10.1073/pnas.122205699 12032354
25. The mGluR theory of fragile X mental retardation. MF Bear KM Huber ST Warren, Trends Neurosci 2004 27 370 377 10.1016/j.tins.2004.04.009 15219735
26. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. SK Koekkoek K Yamaguchi BA Milojkovic BR Dortland TJ Ruigrok R Maex W De Graaf AE Smit F VanderWerf CE Bakker, et al. Neuron 2005 47 339 352 10.1016/j.neuron. 2005.07.005 16055059
27. Age-dependent and selective impairment of long-term potentiation in the anterior piriform cortex of mice lacking the fragile X mental retardation protein. J Larson RE Jessen D Kim AK Fine J du Hoffmann, J Neurosci 2005 25 9460 9469 10.1523/JNEUROSCI.2638-05.2005 16221856
28. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. W Paradee HE Melikian DL Rasmussen A Kenneson PJ Conn ST Warren, Neuroscience 1999 94 185 192 10.1016/S0306-4522(99) 00285-7 10613508
29. Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. L Selby C Zhang QQ Sun, Neurosci Lett 2007 412 227 232 10.1016/j.neulet.2006.11.062 17197085
30. Taurine improves congestive functions in a mouse model of fragile X syndrome. A El Idrissi L Boukarrou C Dokin WT Brown, Adv Exp Med Biol 2009 643 191 198 full-text 19239149
31. Taurine as a modulator of excitatory and inhibitory neurotransmission. A ElIdrissi E Trenkner, Neurochem Res 2004 29 189 197 10.1023/B:NERE.0000010448. 17740.6e 14992278
32. Modulating Inhibitory Ligand-Gated Ion Channels. M Cascio, AAPS J 2006 8 353 E361 16796386
33. Interactions of taurine and structurally related analogues with the GABAergic system and taurine binding sites of rabbit brain. M Frosini C Sesti S Dragoni M Valoti M Palmi HBF Dixon F Machetti G Sgaragli, Br J Pharmacol 2003 138 1163 1171 10.1038/sj.bjp.0705134 12684273
34. A specific taurine recognition site in the rabbit brain is responsible for taurine effects on thermoregulation. M Frosini C Sesti S Saponara L Ricci M Valoti M Palmi F Machetti G Sgaragli, Br J Pharmacol 2003 139 487 494 10.1038/sj.bjp.0705274 12788808
35. Modulation of the GABA-benzodiazepine receptor complex by taurine in rat brain membranes. O Malminen P Kontro, Neurochem Res 1986 11 85 94 10.1007/BF00965168 3008015
36. Modulation of human GABA1 receptors by taurine. LD Ochoa-de la Paza IA Martínez-Dvilaa A Miledia RMartínez-Torres, Neurosci Res 2008 61 302 308 10.1016/j.neures.2008.03.009 18479770
37. A Receptors in the Thalamus. F Jia M Yue D Chandra A Keramidas PA Goldstein GE Homanics NL Harrison, J Neurosci 2008 28 z 106 115 10.1523/JNEUROSCI.3996-07.2008 18171928
38. Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation. N Hussy C Deleuze A Pantaloni MG Desarmenien F Moos, J Physiol 1997 502 609 621 10.1111/j.1469-7793. 1997.609bj.x 9279812
39. Expression and function of glycine receptors in striatal cholinergic interneurons from rat and mouse. OA Sergeeva HL Haas, Neuroscience 2001 104 1043 1055 10.1016/S0306-4522(01)00130-0 11457589
40. Taurine activates excitatory non-synaptic glycine receptors on dopamine neurones in ventral tegmental area of young rats. F Wang C Xiao JH Ye, J Physiol 2005 565 503 516 10.1113/jphysiol.2005.085423 15817633
41. Effect of gamma-aminobutyric acid agonists, glycine, taurine and neuropeptides on acetylcholine release from the rabbit retina. JR Cunningham MJ Neal, J Physiol 1983 336 563 577 6135799
42. B receptors in rat hippocampal CA1 area. N del Olmoa J Bustamanteb RM del Ríoa JM Solís, Brain Res 2000 864 298 307 10.1016/S0006-8993(00)02211-3 10802037
43. Beta-Alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. M Mori BH Gähwiler U Gerber, J Physiol 2002 539 191 200 10.1113/jphysiol.2001.013147 11850512
44. A receptor desensitization: the role of the gamma 2 subunit and its physiological significance. C Dominguez-Perrot P Feltz MO Poulter, J Physiol 1996 497 145 159 8951718
45. A Receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman Syndrome. TM DeLorey A Handforth SG Anagnostaras GE Homanics BA Minassian A Asatourian MS Fanselow A Delgado-Escueta GD Ellison RW Olsen, J Neurosci 1998 18 8505 8514 9763493